UBS Group’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-226,458
| Closed | -$40.7M | – | 7255 |
|
|
2017
Q3 | $40.7M | Buy |
226,458
+170,614
| +306% | +$30.7M | 0.02% | 546 |
|
|
2017
Q2 | $5.79M | Buy |
55,844
+25,964
| +87% | +$2.69M | ﹤0.01% | 1584 |
|
|
2017
Q1 | $2.35M | Sell |
29,880
-76,519
| -72% | -$6.01M | ﹤0.01% | 2232 |
|
|
2016
Q4 | $4.77M | Buy |
106,399
+64,737
| +155% | +$2.9M | ﹤0.01% | 1630 |
|
|
2016
Q3 | $2.33M | Sell |
41,662
-87,509
| -68% | -$4.89M | ﹤0.01% | 2111 |
|
|
2016
Q2 | $6.46M | Buy |
129,171
+87,871
| +213% | +$4.39M | ﹤0.01% | 1328 |
|
|
2016
Q1 | $1.9M | Sell |
41,300
-147,432
| -78% | -$6.77M | ﹤0.01% | 2180 |
|
|
2015
Q4 | $11.6M | Buy |
188,732
+76,734
| +69% | +$4.73M | 0.01% | 998 |
|
|
2015
Q3 | $6.24M | Buy |
111,998
+40,102
| +56% | +$2.23M | ﹤0.01% | 1333 |
|
|
2015
Q2 | $4.38M | Buy |
71,896
+5,942
| +9% | +$362K | ﹤0.01% | 1714 |
|
|
2015
Q1 | $3.8M | Buy |
65,954
+49,861
| +310% | +$2.88M | ﹤0.01% | 1817 |
|
|
2014
Q4 | $928K | Buy |
+16,093
| New | +$928K | ﹤0.01% | 2772 |
|